Evidence map›Paper›PMID 36560453›Full record

ArticleVaccines2022

A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19.

Riccardo Scotto, Amedeo Lanzardo, Antonio Riccardo Buonomo, Biagio Pinchera, Letizia Cattaneo, Alessia Sardanelli, Simona Mercinelli, Giulio Viceconte, Alessandro Perrella, Vincenzo Esposito and 7 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. The SpOJournal of clinical medicine · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Riccardo ScottoDepartment of Clinical Medicine and Surgery-Section of Infectious Diseases, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-0178-2986
Amedeo LanzardoDepartment of Clinical Medicine and Surgery-Section of Infectious Diseases, University of Naples Federico II, 80131 Naples, Italy.
Antonio Riccardo BuonomoDepartment of Clinical Medicine and Surgery-Section of Infectious Diseases, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-4378-8366
Biagio PincheraDepartment of Clinical Medicine and Surgery-Section of Infectious Diseases, University of Naples Federico II, 80131 Naples, Italy.
Letizia CattaneoDepartment of Clinical Medicine and Surgery-Section of Infectious Diseases, University of Naples Federico II, 80131 Naples, Italy.
Alessia SardanelliDepartment of Clinical Medicine and Surgery-Section of Infectious Diseases, University of Naples Federico II, 80131 Naples, Italy.
Simona MercinelliDepartment of Clinical Medicine and Surgery-Section of Infectious Diseases, University of Naples Federico II, 80131 Naples, Italy.
Giulio ViceconteDepartment of Clinical Medicine and Surgery-Section of Infectious Diseases, University of Naples Federico II, 80131 Naples, Italy.
Alessandro PerrellaEmerging Infectous Disease with High Contagiousness Unit, Cotugno Hospital, 80131 Naples, Italy.ORCID 0000-0003-2812-8500
Vincenzo EspositoIVth Division of Immunodeficiency and Gender Infectious Diseases, Cotugno Hospital, 80131 Naples, Italy.
Alessio Vinicio CodellaDepartment of Medical Sciences-Unit of Infectious Diseases, "Gaetano Rummo" Hospital, 82100 Benevento, Italy.
Paolo MaggiInfectious and Tropical Diseases Clinic, AORN Sant'Anna and San Sebastiano, 81100 Caserta, Italy.ORCID 0000-0002-8772-0136
Emanuela ZappuloDepartment of Clinical Medicine and Surgery-Section of Infectious Diseases, University of Naples Federico II, 80131 Naples, Italy.
Riccardo VillariDepartment of Clinical Medicine and Surgery-Section of Infectious Diseases, University of Naples Federico II, 80131 Naples, Italy.
Maria FoggiaDepartment of Clinical Medicine and Surgery-Section of Infectious Diseases, University of Naples Federico II, 80131 Naples, Italy.
Ivan GentileDepartment of Clinical Medicine and Surgery-Section of Infectious Diseases, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-5199-8451
Federico Ii Covid-TeamDepartment of Clinical Medicine and Surgery-Section of Infectious Diseases, University of Naples Federico II, 80131 Naples, Italy.
University of Naples Federico II · ITOspedale D. Cotugno · ITAzienda Ospedaliera G.Rummo · ITFederico II University Hospital · ITOspedale Sant'Anna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated the role of CRP and other laboratory parameters in predicting the worsening of clinical conditions during hospitalization, ICU admission, and fatal outcome among patients with COVID-19. Consecutive adult inpatients with SARS-CoV-2 infection and respiratory symptoms treated in three different COVID centres were enrolled, and they were tested for laboratory parameters within 48 h from admission. Three-hundred ninety patients were enrolled. Age, baseline CRP, and LDH were associated with a P/F ratio < 200 during hospitalization. Male gender and CRP > 60 mg/L were shown to be independently associated with ICU admission. Lymphocytes < 1000 cell/μL were associated with the worst P/F ratio. CRP > 60 mg/L predicted exitus. We subsequently devised an 11-points numeric ordinary scoring system based on age, sex, CRP, and LDH at admission (ASCL score). Patients with an ASCL score of 0 or 2 were shown to be protected against a P/F ratio < 200, while patients with an ASCL score of 6 to 8 were shown to be at risk for P/F ratio < 200. Patients with an ASCL score ≥ 7 had a significantly increased probability of death during hospitalization. In conclusion, patients with elevated CRP and LDH and an ASCL score > 6 at admission should be prioritized for careful respiratory function monitoring and early treatment to prevent a progression of the disease.

Indexed as

COVID-19C-reactive proteinLDHmortalityP/F ratioSARS-CoV-2

Identifiers

PMID36560453
PMCPMC9781962
OpenAlexW4310380854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.